Valeant Pharmaceuticals International
978-613-1-11662-9
6131116628
108
2010-08-05
39.00 €
eng
https://images.our-assets.com/cover/230x230/9786131116629.jpg
https://images.our-assets.com/fullcover/230x230/9786131116629.jpg
https://images.our-assets.com/cover/2000x/9786131116629.jpg
https://images.our-assets.com/fullcover/2000x/9786131116629.jpg
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online.Valeant Pharmaceuticals International is a pharmaceutical company with activities spanning the drug discovery pipeline from target identification through clinical trials and commercialization. The focus of the company is on neurology, dermatology and infectious disease with several drugs in late-stage clinical trials and several currently on the market. In addition, Valeant has a portfolio of more than 500 products from its prior history as a group of speciality chemical and radiochemical research, development and supply companies with a history stretching back to the 1960s.
https://www.morebooks.shop/books/gb/published_by/betascript-publishing/1/products
Pharmacy
https://www.morebooks.shop/store/gb/book/valeant-pharmaceuticals-international/isbn/978-613-1-11662-9